Scout Bio to Present at Upcoming Gene and Cell Therapy Summit
May 19, 2023 10:02 ET
|
ScoutBio
PHILADELPHIA, May 19, 2023 (GLOBE NEWSWIRE) -- Scout Bio, a biotechnology company developing therapeutic proteins and one-time AAV gene therapies for major chronic pet health conditions, today...
Scout Bio Announces Appointment of Chief Manufacturing Officer
July 01, 2022 06:13 ET
|
ScoutBio
PHILADELPHIA, July 01, 2022 (GLOBE NEWSWIRE) -- Scout Bio, a biotechnology company revolutionizing pet medicine by delivering a pipeline of monoclonal antibodies and one-time AAV gene therapies for...
Scout Bio To Present Positive Clinical Data On SB-001 For Feline CKD-Anemia at Leading Veterinary Medicine Forum
June 14, 2022 20:00 ET
|
ScoutBio
Scout Bio’s research was selected for presentation at the American College of Veterinary Internal Medicine (ACVIM) ForumThree lectures will present Scout Bio’s technology, new areas of research, and...
Scout Bio to Feature at Morgan Stanley Animal Health Biopharma Global KOL Summit
June 09, 2022 06:00 ET
|
ScoutBio
PHILADELPHIA, June 09, 2022 (GLOBE NEWSWIRE) -- Scout Bio, a biotechnology company revolutionizing pet medicine by delivering a pipeline of one-time gene therapies and monoclonal antibodies for...
Scout Bio Appoints Life Sciences Executive Aaron Schacht to Board of Directors
February 18, 2022 05:30 ET
|
ScoutBio
Brings experience in managing global innovation portfolios and business development to Scout BioExecutive leadership experience across both animal and human health PHILADELPHIA, Feb. 18, 2022 ...
Scout Bio to Present at Upcoming Animal Health Conferences
February 15, 2022 06:00 ET
|
ScoutBio
PHILADELPHIA, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Scout Bio, a biotechnology company developing therapeutic proteins and one-time AAV gene therapies for major chronic pet health conditions, today...
Scout Bio Expands Gene Therapy Collaboration with the University of Pennsylvania Via Next-Generation Vector Technologies
December 07, 2021 06:05 ET
|
ScoutBio
Partnership agreement includes exclusive rights in animal health to novel viral vector capsid and expands additional option rights to novel capsidsNext-generation novel adeno-associated viral (AAV)...
Scout Bio Named Best New Start-Up for 2021
November 09, 2021 06:00 ET
|
ScoutBio
PHILADELPHIA, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Scout Bio, a biotechnology company focused on one-time AAV gene therapies for major chronic pet health conditions, received top honors as the Best...
Scout Bio Initiates Multi-Center Clinical Study of Gene Therapy for Chronic Arthritis Pain In Cats
October 28, 2021 06:00 ET
|
ScoutBio
- First vectorized antibody gene therapy to be studied in pets- Strong initial in-species data support therapeutic profile of one-time gene therapy designed for long-term pain management- Novel...
Scout Bio Closes $33 Million Series B2 Financing to Advance its Portfolio of Single Injection Gene Therapy Technology for the Treatment of Chronic Diseases in Pets
October 19, 2021 06:08 ET
|
ScoutBio
- Proceeds to support advancing single injection Adeno-Associated Viral (AAV) vector therapeutics targeting chronic companion animal diseases including diabetes, pain, and anemia associated with...